NF-kappa B signaling pathway as a target for human tumor radiosensitization.
about
Preadministration of High-Dose Salicylates, Suppressors of NF- B Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation TherapyNonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferationIntegrated Bioinformatics for Radiation-Induced Pathway Analysis from Proteomics and Microarray Data.Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiationInhibition of cathepsin L sensitizes human glioma cells to ionizing radiation in vitro through NF-κB signaling pathway.The role of the ubiquitin/proteasome system in cellular responses to radiation.MAPK pathways in radiation responses.Calcium/calmodulin-dependent protein kinases as potential targets in cancer therapy.NF-kappa B-mediated adaptive resistance to ionizing radiation.Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naive T-cell priming.Matrix metalloproteinase-9 inhibition down-regulates radiation-induced nuclear factor-kappa B activity leading to apoptosis in breast tumors.Chromosome instability in diffuse large B cell lymphomas is suppressed by activation of the noncanonical NF-κB pathway.Molecularly targeted radiosensitization of human prostate cancer by modulating inhibitor of apoptosis.Identification of survival genes in human glioblastoma cells by small interfering RNA screening.Breast cancer adaptive resistance: HER2 and cancer stem cell repopulation in a heterogeneous tumor society.Metformin targets multiple signaling pathways in cancer.Can the therapeutic gain of radiotherapy be increased by concurrent administration of Asian botanicals?NF-κB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699.Radioprotective Agents: Strategies and Translational Advances.CDK1-Mediated SIRT3 Activation Enhances Mitochondrial Function and Tumor Radioresistance.Radio-sensitization of the murine osteosarcoma cell line LM8 with parthenolide, a natural inhibitor of NF-κB.Ionizing radiation-induced NF-kappaB activation requires PARP-1 function to confer radioresistanceMitogen-activated protein kinase phosphatase-1 represses c-Jun NH2-terminal kinase-mediated apoptosis via NF-kappaB regulationDominant-negative cAMP-responsive element-binding protein inhibits proliferating cell nuclear antigen and DNA repair, leading to increased cellular radiosensitivity.Cellular origin of ionizing radiation-induced NF-kappaB activation in vivo and role of NF-kappaB in ionizing radiation-induced lymphocyte apoptosis.Activated nuclear factor-kappa B and cytokine profiles in the esophagus parallel tumor regression following neoadjuvant chemoradiotherapy.Imaging of nuclear factor κB activation induced by ionizing radiation in human embryonic kidney (HEK) cells.NF-κB inhibition by dimethylaminoparthenolide radiosensitizes non-small-cell lung carcinoma by blocking DNA double-strand break repair.
P2860
Q22299231-7CBC604C-0303-4D3E-B528-A26952F9C4ABQ28171193-6FDCC77F-B550-4728-BE4A-EC62EEDFB518Q33393648-7D8DCCE6-73E4-487A-A444-19942B213487Q34405013-6A2AC57A-3168-4833-8EEC-670DC97FAC79Q35148208-37E69D27-84DE-4ABB-BD40-18B4BBF78EFBQ35208807-24B5FC9D-9B76-40DC-B9B0-AC7BD08BC829Q35208830-C74F6851-3348-41C4-82C3-AA9E291BC179Q36219718-0243E714-DF3B-4B8E-BC6A-40032F06D9C4Q36493029-4DF7CAEB-81CE-46A9-8B48-D865C90BE0E2Q36616735-CDDE8A09-FCBF-4D97-B265-253A3606F250Q36696163-CAE0748C-5A08-4527-932F-3A809D1635C0Q36935112-EBB25D25-BFDC-45CE-8B86-BA2EC92D4ABBQ37020757-DF8849FF-2FED-4F77-BE45-E860E5743B12Q37444479-0A75F94E-25FE-44FF-8BE9-E8F06F2A8D2BQ37470093-E11D2535-6C8B-4B8C-A136-35D013FC2B03Q37609790-A755A38F-F7D7-45BE-BD7E-1F3CA94B6775Q37665033-AAF6D721-6AE4-4517-8384-DD6210E70837Q38677373-79037066-0FE3-47F2-8BEC-2A2DE27BC981Q38710560-D9508401-EF3B-4CA4-961C-33DCDF9E13DEQ38856771-84A683EC-2EB8-49F8-81C9-EE45A6D41559Q39551263-F2C8DC4C-5DF5-4010-884E-FE997E66D718Q39908141-B0C6CE59-0ED6-4D77-94F1-CC8D2003D6DDQ39977638-335EB69A-AE76-4F5C-A606-7741911900E9Q42440806-42073B8A-CF0B-441C-A970-FD830B1040C4Q44708960-332AC492-8F9F-4D1B-B190-8E2F8FB95523Q46675019-4182ED41-9E93-461B-9846-A2137CF426AFQ50470102-10BCC2AD-7737-4D18-BAED-1237B61CE563Q55070937-3BFC69DE-D320-4AE6-B59B-7847E865193D
P2860
NF-kappa B signaling pathway as a target for human tumor radiosensitization.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
NF-kappa B signaling pathway as a target for human tumor radiosensitization.
@ast
NF-kappa B signaling pathway as a target for human tumor radiosensitization.
@en
NF-kappa B signaling pathway as a target for human tumor radiosensitization.
@nl
type
label
NF-kappa B signaling pathway as a target for human tumor radiosensitization.
@ast
NF-kappa B signaling pathway as a target for human tumor radiosensitization.
@en
NF-kappa B signaling pathway as a target for human tumor radiosensitization.
@nl
prefLabel
NF-kappa B signaling pathway as a target for human tumor radiosensitization.
@ast
NF-kappa B signaling pathway as a target for human tumor radiosensitization.
@en
NF-kappa B signaling pathway as a target for human tumor radiosensitization.
@nl
P356
P1476
NF-kappa B signaling pathway as a target for human tumor radiosensitization.
@en
P2093
P304
P356
10.1053/SRAO.2001.26034
P577
2001-10-01T00:00:00Z